Cell Harvesting System Market

Report Overview

The Cell Harvesting System Market is expected to be worth around USD 22,933.57 million by 2031 from USD 6,076.8 million in 2021, growing at a CAGR of 14.2% during the forecast period from 2021 to 2031.

The Cell Harvesting System Market growth is driven by rising demand for stem cell-based treatment and increased investment in scientific research due to its possible benefits in recovering medicines.

Global Cell Harvesting System Market Scope:

Application analysis

This technique can be used for stem cells extracted from the bone marrow, peripheral blood, and umbilical cord. Peripheral blood dominated the market in 2016. It is expected to preserve its dominant position over the forecast period time. This is due in part to the growing use of marginal Plasma in stem-cell replacement and in part to the increased use in stem-cell research.

Adipose tissue will see the greatest growth due to liposuction’s ability to extract more stem cells and potentially use these harvesting processes in regenerative medicines. The potential for its use in other therapies and increasing transplantation use will be major factors in the umbilical cord’s lucrative growth factor.

End-Use analysis

According to end-use, there is four segment scope of the market: academic institutes, clinics, and hospitals. Hospitals hold the largest market share and will continue to dominate over the coming years. This is because most stem cell transplants and research take place in hospitals.

Higher investment by universities and biopharmaceutical industry corporations in research will lead to the greatest growth of academic institutes, R&D centers, and R&D centers. The rising demand for skin cell-based treatments and regenerative medicine will drive research in academic institutions to continue to expand.

Кеу Маrkеt Ѕеgmеntѕ

By Application

• Umbilical Cord
• Bone Marrow
• Peripheral Blood
• Adipose tissue
• Other sources

By End-Use

• Hospitals
• Clinics
• Academic institutes
• R&D centers

Cell Harvesting System Market Dynamics:

Stem cell-based therapy will continue to grow in demand for stem cell systems due to an aging population and the rising prevalence of chronic diseases such as heart disease. Stem cell-based research has seen a dramatic increase in the last decade. This is a major driving factor in the demand for cell harvesting for research. The National Institutes of Health (NIH), the primary U.S. agency for biomedical research and public health, spent USD 1.49 billion on research in 2016. This was approximately 5.0% more than in 2015.

Stem cell banking is also rising due to the increasing transplantation rate. Research into stem cell sources such as embryonic stem cells and umbilical cord stem cells drives the development of regenerative products and cancer treatment.

The market’s growth will be limited by ethical concerns regarding embryonic stem cells and unapproved stem cell therapy offered by healthcare providers in unregulated areas such as Latin America and Asia Pacific.

Regional Analysis

North America and Europe comprised 74% of the total revenue, while Europe dominated in 2021. It is also home to the majority of stem cell transplants. Europe holds a larger Cell Harvesting System Market share of the Cell Harvesting System Market.

North American market was the leading research region regional scoop in 2021, with over 54.5% of stem cell clinical trials performed in this area. The second main stem cell replacement is also found in this province. This increases the need for garnering.

Asia Pacific is expected to see significant growth rates of long-lasting disease modeling and increased demand for stem cell replacement. Asia Pacific’s top stem cell harvesting system market share includes China and Japan. The forecast period will see developing nations such as South Korea, South Africa, and Mexico experience significant growth. These countries have a rising demand for stem cell therapies. This is due to the higher investment of governments in stem cell-based research.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East
  • GCC
  • South Africa
  • Israel
  • Rest of the Middle East

Market Share & Key Players Analysis:

Terumo Corporation offers a variety of products, including harvesters and apheresis systems. Terumo BCT established a strategic partnership with Cognate Bioservices, a service contract company Share, in September 2016 to develop immunotherapy products and increase the use of quantum systems in cell therapy manufacturing.

Маrkеt Кеу Рlауеrѕ:

• Argos Technologies, Inc.
• Perkin Elmer Inc
• Brand GmBh + CO KG
• Aralon Color GmbH
• Arthrex Inc.
• Microchip Technology Inc.
• Linear technology
• Avita Medical.
• Tomtec
• Bionic Power Inc.
• Convergence Inc.
• Terumo BCT Inc.
• Teleflex Inc.
• Bertin
• Other Key players

---

For the Cell Harvesting System Market research study, the following years have been considered to estimate the market size: